Aerobid Warnings and Precautions
Knowing Aerobid warnings and precautions prior to starting the medication can help minimize risks and ensure safe treatment. Some warnings with this medicine include telling your healthcare provider immediately if your asthma worsens, making sure you have a rescue inhaler on hand at all times, and avoiding Aerobid if you allergic to any components of the drug. Some potential side effects of Aerobid to be aware of include thrush, glaucoma or cataracts, and slowing of growth in children or teens.
Aerobid inhalers will not be made, dispensed, or sold in the United States after June 30, 2011. Aerobid contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. People taking Aerobid should ask their healthcare providers about alternatives to Aerobid, keeping in mind that it is possible that Aerobid may become unavailable in pharmacies earlier than the final date.
You should talk with your healthcare provider prior to taking Aerobid® (flunisolide inhaler) if you have:
- Not had chickenpox or the measles (or have not been vaccinated against them)
- Eczema (or atopic dermatitis)
- Tuberculosis, herpes, or any other infections
- Glaucoma or cataracts
- Any allergies, including allergies to food, dyes, or preservatives.
Also let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
You should also make sure to tell your healthcare provider about all other medicines you may be taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.